Al Brooks discusses the risk of approving a Covid-19 vaccine prematurely in the first of this week’s two-part update.

As you know, I like articles in highly reputable, peer reviewed journals because the information that they publish is much more likely to be true. With that in mind, I am including links to several articles I think are interesting.

The importance of safe vaccines

Many people avoid vaccines out of fear. Many others who would normally be eager to get a Covid-19 vaccine will be less eager this time. This is because lots of scientists are expressing concerns over safety.

Covid-19 safe vaccine clinical trial

They are afraid that the White House is going to pressure the Food and Drug Administration (FDA) into reducing the safety requirements so that a vaccine will be out before the election.

I personally am eager for a vaccine, but I do not trust some of the government’s scientists to do what is right for the public. Several have demonstrated that they are willing to lie to keep the White House happy.

For example, the Centers for Disease Control and Prevention (CDC) told governors this week (see below) that they need to be prepared for a vaccine being available by the end of October. I bet every medical expert in the country believes they were forced to say that by the White House.

Why? Because it is very unlikely to be true. Is there a reason other than political pressure from the White House to say something untrue? This falsehood will generate a lot of hope and enthusiasm in the week before the election, which will benefit the president.

The leaders of the CDC and FDA know that the White House has an extensive history of punishing people who did not help it politically. People who should be non-political are put in a difficult position. They have to choose between keeping their jobs and tarnishing their reputations. Many have made a choice to benefit their careers at a cost to the rest of us.

CDC says vaccine might be available in late October

There are currently two clinical trials in stage 3 of testing. Each has 30,000 patients and they should conclude by the end of the year. Dr. Anthony Fauci said that an independent board has the authority to end the trials several weeks early if the results are overwhelmingly positive or negative.

The Centers for Disease Control and Prevention (CDC) sent a letter to governors to have their public health officials prepared to distribute a Covid-19 vaccine in late October. States will have to alter their current guidelines to allow the use of vaccines that are still in clinical trials.

The CDC release says, “Limited COVID -19 vaccine doses may be available by early November 2020, but COVID-19 vaccine supply will increase substantially in 2021.”

The CDC is not saying that a vaccine will be available in the week before the election. All they are saying is that the states need to be prepared for a vaccine just ahead of the election.

Once there finally is an approved vaccine, it will be first available to high risk people, which includes first responders, nursing home residents and staff and essential workers. After that, presumably other at risk people will get priority. These include those over 65 and those pre-existing conditions.

Then, finally, it will be available to anyone who wants it. Since we need hundreds of millions of doses, the first widespread vaccinations will probably be in late winter at the earliest. And again, this is true only if a vaccine is safe and effective.

The FDA might approve a vaccine before safety tests are complete

Suppose the FDA and the CDC announce that they are extremely concerned about nearly 200,000 dead Americans. What if they then say that this is such an urgent problem that they revised the safety requirements so that the FDA could approve vaccines much earlier than possible under the current guidelines?

Avoid vaccines for Covid-19 not tested for safety

I and a lot of other medical scientists will not believe that this is in the public’s best interest. We will conclude that it is only being done because of political pressure to help the President. If I feel that the vaccine has not been fully tested, I will wait.

Vaccines have a history of disasters

Why wait? Because there is a track record of serious problems with vaccines. In 1955, we used a polio vaccine from Cutter Labs on 200,000 kids. It turns out that one batch contained live polio vaccine and 40,000 of the kids got polio.

Over the next decade, scientists used monkeys to create polio vaccines. What they did not know is that many of the monkeys had a virus (simian virus 40), and 10% to 30% of the polio vaccines contained that monkey virus.

In 1976, there was a swine flu. President Ford believed the scientists who said that this flu could turn into a pandemic. They therefore rushed a vaccine through and gave it to 40 million people. About 1 in 100,000 people came down with Guillain-Barre syndrome, which is a type of paralysis.

Is rushing a vaccine worth it?

So, what if the FDA rushes through a vaccine this time to help the president? Dr. Howard Markel, the director of the Center for the History of Medicine at the University of Michigan has a simple answer, “It would be colossally stupid.”

Vaccine testing goes through three stages. The third and final one is the most important. It typically involves tens of thousands of volunteers and the FDA needs it to confirm the safety and effectiveness of a vaccine.

However, the FDA is talking about approving vaccines before stage 3 is complete. Dr. Markel warned, “This is one of the most ridiculous things I’ve heard this administration say. All it takes is one bad side effect to basically botch a vaccine program that we desperately need against this virus. It’s a prescription for disaster.”

Some news is just not interesting

Johnson and Johnson (JNJ) reported that a single dose of their vaccine prevents infections in hamsters. They exposed the hamsters to the virus four weeks later and the vaccinated hamsters did not appear to get sick.

Hamster after Covid-19 vaccine test

We are already late in clinical trials on humans. I’m not that interested in rodent studies. Also, this is annoying because this should have been done before testing it on people. My take-away is that I will make sure to vaccinate the next hamster that I buy so that he won’t get Covid-19.

In the second part of this week’s Covid-19 update, we will discuss antibody shelf life and the value of steroids in treating severe Covid-19 cases.

Al Brooks’ earlier special reports on the Covid-19 pandemic:

COVID-19 Update: Beverly Hills Pseudoscientists & the Importance of Real Scientific Validation

Trading Course and Trading Room

Al teaches how to trade consistently like a professional with his comprehensive online Brooks Trading Course. Traders can see an end of day bar-by-bar price action report by signing up for free at BrooksPriceAction.com. Al talks about the detailed E-mini price action real-time throughout the day in the BrooksPriceAction.com trading room. We offer a two-day free trial.